Naples, Italy

Michele D'Urso


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 27(Granted Patents)


Company Filing History:

goldMedal1 out of 832,680 
Other
 patents

Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michele D'Urso: Innovator in Medical Diagnosis and Treatment

Introduction

Michele D'Urso is a notable inventor based in Naples, Italy. He has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of conditions associated with defective NF-kappa B activation. His work has the potential to impact many lives, especially those affected by neurocutaneous genodermatosis.

Latest Patents

Michele D'Urso holds a patent for a method related to the diagnosis and treatment of Incontinentia Pigmenti (IP). This condition is an X-linked dominant disorder that poses a high risk of prenatal male lethality. His patent outlines methods, compositions, and kits aimed at addressing defects in NF-kappa B related diseases, such as IP. The patent is a testament to his innovative approach in tackling complex medical issues.

Career Highlights

Throughout his career, Michele D'Urso has focused on advancing medical research and developing effective treatments. His dedication to understanding the underlying mechanisms of diseases has led to groundbreaking discoveries. His work is characterized by a commitment to improving patient outcomes through innovative solutions.

Collaborations

Michele has collaborated with esteemed colleagues, including Sue J Kenwrick and Hayley Woffendin. These partnerships have fostered a collaborative environment that enhances the research and development of new medical technologies.

Conclusion

Michele D'Urso's contributions to medical science through his patent and collaborative efforts highlight his role as an innovator in the field. His work continues to pave the way for advancements in the diagnosis and treatment of complex medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…